Company
MPH HEALTH CARE AG KONV
Headquarters: Berlin, Germany
CEO: Mr. Patrick Brenske
Market Cap
€112.2 Million
EUR as of July 1, 2024
US$120.5 Million
MPH HEALTH CARE AG KONV Categories
Germany Healthcare Drug Manufacturers—Specialty & GenericGermany Healthcare Germany Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
MPH Health Care AG, an investment company engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic admixture and concomitant medications; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
MPH HEALTH CARE AG KONV has the following listings and related stock indices.
Stock: XETR: 93M1 wb_incandescent
Stock: FSX: 93M1 wb_incandescent